Theresa M. Schwartz, MS, NP-C
Ms. Schwartz is a native of New York City, received her undergraduate education in Buffalo, and her graduate nursing degree from the University of Rochester Nurse Practitioner program as a Family Nurse Practitioner in 1981. She then became the first Vascular Surgery Nurse Practitioner at Strong Memorial Hospital and has taught nursing at MCC, as well as in the Nurse Practitioner program at the UR before becoming an HIV provider from 1998 through 2010. During that time she completed a two year HIV fellowship through the New York State Department of Health's AIDS Institute in 2005, and maintained HIV Specialist certification through the American Academy of HIV Medicine.
In 2005 she completed specialty Anoscopy training in New York City and since then has been practicing at Rochester Colon and Rectal Surgeons, performing High Resolution Anoscopy (HRA) for diagnosis and Infrared Photocoagulation (IRC) for treatment of anal dysplasia / precancers. She also initiated and was the Medical Director of the Anal Dysplasia Clinic at Strong Memorial Hospital for six years. Ms. Schwartz was the first provider in New York State outside of New York City, to offer HRA. She has since taught these important and life-saving procedures to providers in Chicago, Buffalo, Rochester, Syracuse and New York City. She has authored several articles regarding anal dysplasia, is active with the International Association of Anal Neoplasia (IANS), and has participated in anal dysplasia research through the AIDS Clinical Trials Group (ACTG).
Ms. Schwartz has provided numerous presentations to NP, PA, MD, and lay groups regarding the Human Papillomavirus (HPV), which is the virus that causes cervical cancer in women and anal cancer in men and women. Over 2,000 of her patients have benefited from having precancerous lesions removed from their anal canals, avoiding the much more extensive treatment for invasive anal cancer, which can be fatal if not caught early. She has also served on the Speaker's Bureau for Merck Pharmaceuticals, to educate health care providers about the importance of administering Gardasil vaccine to prevent HPV infections to all males and females between the ages of 9 and 26 in order to prevent oral cancer, throat cancer, cervical cancer, penile cancer and anal cancer later in life.